Alexandria Real Estate Equities, Inc. logo ARE - Alexandria Real Estate Equities, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 9
HOLD 14
SELL 2
STRONG
SELL
0
| PRICE TARGET: $53.75 DETAILS
HIGH: $60.00
LOW: $50.00
MEDIAN: $52.50
CONSENSUS: $53.75
UPSIDE: 1.61%

Stock News

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $1,000,000,000 of Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $1,000,000,000 of Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057

PASADENA, Calif., Aug. 12, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $1,000,000,000 aggregate principal amount of 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057 (the "notes").

Aug 12, 2026 02:20 PM prnewswire.com
Alexandria Real Estate: Market Missing A Recovery Coming Sooner Than Expected

Alexandria Real Estate: Market Missing A Recovery Coming Sooner Than Expected

Alexandria Real Estate is showing clear signs of fundamental recovery, with Q2 results and Q3 guidance exceeding expectations. Leasing momentum is accelerating, highlighted by a 60% QoQ increase in leasing volumes and strong tenant retention, signaling a flight to quality. Capital recycling is focused on monetizing non-core assets, especially land, to protect core cash-generating properties and strengthen the balance sheet.

Aug 04, 2026 04:53 AM seekingalpha.com
Alexandria Real Estate Equities, Inc. Announces Foundational Milestone in Mission-Critical Partnership with the Foundation for the National Institutes of Health to Advance Precision Medicine for Depression

Alexandria Real Estate Equities, Inc. Announces Foundational Milestone in Mission-Critical Partnership with the Foundation for the National Institutes of Health to Advance Precision Medicine for Depression

PASADENA, Calif, July 29, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation clusters, today announced with the Foundation for the National Institutes of Health (FNIH) that the Multi-Modal Assessment and Phenotyping in Depression (MAP-D) initiative has successfully completed its critical design phase, marking a foundational milestone toward a first-of-its-kind clinical study designed to redefine how major depressive disorder is diagnosed and treated through precision medicine. Launched with Alexandria's vision and first funding, and founded on its strategic partnership with the FNIH, MAP-D seeks to identify and validate biological signatures of depression that can enable more personalized treatment approaches, accelerate the development of more effective therapies and ultimately improve outcomes for millions of patients.

Jul 29, 2026 04:30 AM prnewswire.com
Arrowstreet Capital Limited Partnership Makes New Investment in Alexandria Real Estate Equities, Inc. $ARE

Arrowstreet Capital Limited Partnership Makes New Investment in Alexandria Real Estate Equities, Inc. $ARE

Arrowstreet Capital Limited Partnership acquired a new stake in Alexandria Real Estate Equities, Inc. (NYSE: ARE) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 788,845 shares of the real estate investment trust's stock, valued at approximately $36,618,000. Arrowstreet Capital Limited

Jul 28, 2026 11:57 PM defenseworld.net
Hudson Pacific Properties (NYSE:HPP) and Alexandria Real Estate Equities (NYSE:ARE) Financial Review

Hudson Pacific Properties (NYSE:HPP) and Alexandria Real Estate Equities (NYSE:ARE) Financial Review

Hudson Pacific Properties (NYSE: HPP - Get Free Report) and Alexandria Real Estate Equities (NYSE: ARE - Get Free Report) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Earnings and Valuation This table

Jul 25, 2026 09:59 PM defenseworld.net

Price Targets